Flavokawain A suppresses the malignant progression of neuroblastoma in vitro depending on inactivation of ERK/VEGF/MMPs signaling pathway
Mengyao Dong, Gaiqin Li, Geng Geng, Ming Ming, Yongtao Xu · 2024
Read Flavokawain A suppresses the malignant progression of neuroblastoma in vitro depending on inactivation of ERK/VEGF/MMPs signaling pathway by Mengyao Dong, Gaiqin Li, Geng Geng, Ming Ming, Yongtao Xu (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11576677.txt.
Description
Mengyao Dong and co-authors test a kava plant compound against neuroblastoma in the dish, in a 2024 paper. Neuroblastoma is the commonest solid tumor outside the brain in children, and its outlook is often poor. Flavokawain A, a chalcone from kava roots, has slowed several cancers; this study puts it to the pediatric one.
Treated tumor cells grew and cloned less, died more readily, stalled their cell cycle, and lost their drive to migrate, invade, and sprout blood-vessel growth. The compound worked by switching off the ERK/VEGF/MMPs signaling chain, and a rescue test with an ERK activator confirmed the pathway's role. Dose after dose, the pattern held. The results nominate the plant molecule as a candidate worth animal testing.
Catalog record
| CREATOR | Mengyao Dong, Gaiqin Li, Geng Geng, Ming Ming, Yongtao Xu |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 26 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |